Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Early Detection of Cancer × Genetic Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 12 Prostatic Neoplasms 9 Colorectal Neoplasms 6 Endometrial Neoplasms 5 Ovarian Neoplasms 4 Colonic Neoplasms 4 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Brain Neoplasms 3 Wilms Tumor 2 Urogenital Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Neoplasms, Unknown Primary 2 Neoplasm Metastasis 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Hereditary Breast and Ovarian Cancer Syndrome 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2 Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1 Unspecified Childhood Solid Tumor, Protocol Specific 1 Tuberous Sclerosis 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Neoplasms 1 Sarcoma 1 Primary Ovarian Insufficiency 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Genetic Testing 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03897374 2025-01-28

STOP-Cancer

ClinLogic LLC

120,000 enrolled

Early Detection of Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡